Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Klinger

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Chest|August 9, 2021
Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?James R Klinger
Cardiology Clinics|July 23, 2016
Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and TreatmentsJames R Klinger
Comprehensive Physiology|September 24, 2021
Novel Pharmacological Targets for Pulmonary Arterial HypertensionJames R Klinger
Critical Care Clinics|March 26, 2002
Inhaled nitric oxide in ARDSJames R Klinger
The European Respiratory Journal|November 2, 2016
Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension?James R Klinger
Seminars in Cardiothoracic and Vascular Anesthesia|May 31, 2007
Pulmonary arterial hypertension: an overviewJames R Klinger
Clinics in Chest Medicine|March 7, 2007
The nitric oxide/cGMP signaling pathway in pulmonary hypertensionJames R Klinger
Expert Review of Respiratory Medicine|June 28, 2011
Tadalafil for the treatment of pulmonary arterial hypertensionJames R Klinger
Drug Design, Development and Therapy|November 19, 2009
Ambrisentan for the treatment of pulmonary arterial hypertensionBrian Casserly, James R Klinger
Expert Opinion on Investigational Drugs|October 26, 2023
Emerging pharmacotherapies for the treatment of pulmonary arterial hypertensionRoger Auth, James R Klinger
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Chest|August 9, 2021
Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?James R Klinger
Cardiology Clinics|July 23, 2016
Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and TreatmentsJames R Klinger
Comprehensive Physiology|September 24, 2021
Novel Pharmacological Targets for Pulmonary Arterial HypertensionJames R Klinger
Critical Care Clinics|March 26, 2002
Inhaled nitric oxide in ARDSJames R Klinger
The European Respiratory Journal|November 2, 2016
Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension?James R Klinger
Seminars in Cardiothoracic and Vascular Anesthesia|May 31, 2007
Pulmonary arterial hypertension: an overviewJames R Klinger
Clinics in Chest Medicine|March 7, 2007
The nitric oxide/cGMP signaling pathway in pulmonary hypertensionJames R Klinger
Expert Review of Respiratory Medicine|June 28, 2011
Tadalafil for the treatment of pulmonary arterial hypertensionJames R Klinger
Drug Design, Development and Therapy|November 19, 2009
Ambrisentan for the treatment of pulmonary arterial hypertensionBrian Casserly, James R Klinger
Expert Opinion on Investigational Drugs|October 26, 2023
Emerging pharmacotherapies for the treatment of pulmonary arterial hypertensionRoger Auth, James R Klinger
Pageof 12